Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
Center for Strategic and International S...
Senator Ted Cruz of Texas discusses the ...
FOX Business host Larry Kudlow discusses...
Jay Goldberg, senior analyst at Seaport ...
Scott Devitt, Wedbush equity research an...
Novo Nordisk Chief Executive Officer Mik...
Renaissance Macro Research Head of Econo...
Bloomberg’s Caroline Hyde and Ed Ludlow ...
'The Big Money Show' breaks down the eco...
On this week's episode of CNBC Crypto Wo...
On today's episode of Bloomberg Business...
'The Big Money Show' discusses the Trump...
Palantir CTO Shyam Sankar explains how A...